On-Demand Online Seminar:
"Initiative Germany as a Location for Clinical Trials (Initiative Studienstandort Deutschland)"
In this complimentary on-demand online seminar Dr. Grit Andersen, Director Clinical Pharmacology and Deputy Head Project Development, will introduce you the Initiative Germany as a Study Location (Initiative Studienstandort Deutschland). This is an initiative to to address the critical need for substantial improvements in Germany as a prime location for research and development.
Watch this educational online seminar and benefit by:
- Understanding the initiative's mission and key organizations involved.
- Exploring current trends and challenges in Germany's clinical research.
- Learning about strategic goals to boost Germany's research competitiveness.
- Discussing and proposing solutions to improve clinical study conditions.
- Share insights and feedback to shape future clinical research initiatives.
Online Seminar synopsis
Join us for an engaging live online seminar on the "Initiative Studienstandort Deutschland", a joint initiative launched in November 2023 following a pivotal study by vfa and Kearney. This initiative aims to address the critical need for substantial improvements in Germany as a prime location for research and development. A recent analysis by the vfa highlighted a worrying decline in industry-sponsored pharmaceutical research, with Germany initiating only 524 new studies in 2022, well behind Spain's 628 studies in the same year. This is in stark contrast to the nearly 700 studies in which Germany participated in 2015.
Our live online seminar session will introduce you some of the organisations and institutions involved in this initiative, all of which are dedicated to improving the framework for clinical research in Germany. We will explore the key activities and discussions around optimising the conduct of clinical trials, as well as the initiative's active role in shaping policy, such as the new Medical Research Act.
Participants will have the opportunity to learn about the goals of the initiative, share their ideas and make suggestions to strengthen Germany's position as a leading trial location. This seminar is a unique platform for stakeholders to collaborate and drive the future of clinical research in Germany.
For whom:
- Clinical researchers and professionals
- Pharmaceutical company representatives
- Policy makers and regulators
- Academic researchers and institutions
- Anyone interested in the advancement of clinical research in Germany
Takeaway:
Join us to explore how the Initiative Studienstandort Deutschland is driving pivotal changes to revitalize Germany's role in clinical research. Your insights and ideas are crucial in shaping a stronger, more competitive landscape for pharmaceutical studies in Germany.
Meet the presenter
Dr. Grit Andersen has worked as a physician in several medical fields such as surgery, general medicine and neurology in Germany and Costa Rica. She started working in clinical research in 1999 in an international Phase III study in Latin America as an Investigator for a study testing Eletriptan in patients with migraine. She worked for 12 years in early phase studies, especially in First-in-Human studies, and started working at Profil in 2013. She is a board certified medical specialist in clinical pharmacology and as Director Clinical Pharmacology she runs the specialisation program in clinical pharmacology for medical doctors at Profil.
Share this online seminar with your colleagues:
